MDXHNasdaqServices-Medical Laboratories
MDxHealth SA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026
$0.18−0.02 (-11.33%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns MDxHealth's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 0 sales
Net bought $991.19K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Exact Sciences Corporation | 6,441,171 | 12.00% | 13G (passive) amendment | Jan 9, 2026 |
| Lytton Laurence W | 4,943,464 | 9.60% | 13G (passive) amendment | Jun 30, 2026 |
| MVM Partners, LLC | 4,700,457 | 9.94% | 13D (active) amendment | Sep 27, 2024 |
| Bleichroeder Holdings LLC | 31,648,563 | 33.20% | 13D (active) | Aug 11, 2026 |
| Andrew Gundlach | 30,571,922 | 32.04% | 13D (active) amendment | Oct 13, 2026 |
| Laurence W. Lytton | 18,558,988 | 19.50% | 13G (passive) amendment | Aug 13, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael McGarrity | Chief Executive Officer, Director | 95,000 | 0.18% | Jun 3, 2026 |
| Joseph Sollee | See Remarks | – | – | Jun 3, 2026 |
| John Bellano | Chief Commercial Officer | – | – | Jun 3, 2026 |
| Brendan OConnell | VP, Finance and Accounting | – | – | Jun 3, 2026 |
| Ron Kalfus | Chief Financial Officer | – | – | Apr 13, 2026 |
| Eric Bednarski | Director | 6,903,100 | 13.44% | Aug 17, 2026 |
| MVM Partners, LLC | Director | 4,700,457 | 9.15% | Aug 17, 2026 |
| Koen Hoffman | Director | – | – | Jun 3, 2026 |
| Don M. Hardison | Director | – | – | Jun 3, 2026 |
| Sanford Jay Siegel | Director | – | – | Jun 3, 2026 |
| Hilde Windels | Director | – | – | Jun 3, 2026 |
| Michael Holder | Director | – | – | Jun 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eric Bednarski Director | Aug 13, 2026 | Buy | +2,202,643 | $0.45 | $991.19K | 6,903,100 |
| MVM Partners, LLC 10% owner | Feb 3, 2023 | Buy | +1,000,000 | $4.00 | $4.00M | 45,504,584 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| LP Bleichroeder 10% Stockholder | Sep 17, 2026 | 1,500,000 | $1.06M | Sep 17, 2026 | Registered Public Offering |